Retinal vein occlusion is blockage of retinal vein due to blood clot. Retinal vein occlusion is the second most common cause of visual impairment globally. Blood clot causes blockage in the vein, which starts draining blood from retina, resulting in swelling and bleeding, affecting the vision of the person. Depending on the site of blood clot, there are two major types of retinal vein occlusion. Blockage of the central retinal vein leads to central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) involves blockage of smaller branch of veins of the retina. The primary causes of retinal vein occlusion are atherosclerosis, hypertension, and eye conditions such as glaucoma and vitreous hemorrhage.

Rise in prevalence of eye diseases globally, increase in geriatric population, surge in awareness about eye disorders, improved health care infrastructure, technological advancements, and upcoming novel treatments are the major drivers of the global retinal vein occlusion market. However, side effects associated with the treatment act as a major restraint of the global market.

The global retinal vein occlusion market can be segmented based on type, condition, diagnosis, treatment, end-user, and region. In terms of type, the global market can be bifurcated into central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). The branch retinal vein occlusion (BRVO) segment dominated the market in 2017 and the trend is projected to continue during the forecast period. Growth of the segment is attributed to high prevalence of BRVO compared to CRVO. Based on condition, the global retinal vein occlusion market can be classified into ischemic and non-ischemic. The non-ischemic segment dominated the market in 2017 and is expected to continue its dominance during the forecast period. In terms of diagnosis, the market can be divided into fundoscopic examination, optical coherence tomography (OCT), fluorescein angiography, and others. The optical coherence tomography (OCT) segment dominated the market in 2017 due its wide acceptance for the diagnosis of retinal vein occlusion. The segment is likely to sustain its market share during the forecast period. Based on treatment, the global retinal vein occlusion market can be categorized into anti-vascular endothelial growth factor (VEGF) drugs, corticosteroid drugs, pan-retinal photocoagulation therapy, laser therapy, and others. The anti-VEGF drugs segment dominated the market due to preference for these drugs as first line of treatment for BRVO. The segment is projected to sustain its leadership position from 2018 to 2026. In terms of end-user, the market can be classified into hospitals, ophthalmic clinics & research centers, and others. The hospitals segment dominated the market in 2017 and the trend is likely to continue in the next few years, due to increase in preference for hospitals for the treatment of eye related diseases.

In terms of region, the global retinal vein occlusion market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global retinal vein occlusion market in 2017 and is projected to capture significant share during the forecast period. The market in the region is anticipated to grow at a rapid pace due to improved health care infrastructure, rise in prevalence of eye diseases, advanced technology, and increase in the geriatric population. An article published by NCBI stated that central retinal vein occlusion is one of the major causes of sudden, painless vision loss in adults. In developed countries, prevalence of retinal vein occlusions is approximately 5.20 per 1000, and the prevalence of central retinal vein occlusion is 0.8 per 1000. The market in Asia Pacific is anticipated to expand at a high CAGR in the next few years, due to rise in the geriatric population, improvement in health care infrastructure, and increase in awareness about eye disorders in developing countries.

Major players operating in the global retinal vein occlusion market include GlaxoSmithKline plc, Sanofi, Johnson & Johnson Services, Inc., AstraZeneca, Bausch & Lomb Incorporated, Bristol-Myers Squibb Company, Bayer AG, Sun Pharmaceutical Industries Ltd., Regeneron, and Allergan.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Retinal Vein Occlusion Market

Pre Book